Capstone Investment Advisors, LLC Abbott Laboratories Put Options Transaction History

Capstone Investment Advisors, LLC

$30.4 Billion
Q3 2024

Put Options

26 transactions

Quarter	Operation	Price Per put	puts change	puts Held
Q3 2024 Nov 14, 2024	BUY	$100.07 - $118.13 $1.07 Million - $1.26 Million	10,700 Added 5.04%	223,000 $25.4 Million
Q2 2024 Aug 14, 2024	BUY	$100.73 - $112.44 $9.94 Million - $11.1 Million	98,700 Added 86.88%	212,300 $22.1 Million
Q1 2024 May 01, 2024	SELL	$109.52 - $120.96 $8.52 Million - $9.41 Million	-77,800 Reduced 40.65%	113,600 $12.9 Million
Q4 2023 Feb 12, 2024	BUY	$90.19 - $110.4 $10.3 Million - $12.7 Million	114,600 Added 149.22%	191,400 $21.1 Million
Q3 2023 Nov 13, 2023	SELL	$95.53 - $114.62 $582,733 - $699,182	-6,100 Reduced 7.36%	76,800 $7.44 Million
Q2 2023 Aug 10, 2023	BUY	$100.78 - $112.29 $544,212 - $606,366	5,400 Added 6.97%	82,900 $9.04 Million
Q1 2023 May 09, 2023	SELL	$96.86 - $114.01 $10.9 Million - $12.9 Million	-112,900 Reduced 59.3%	77,500 $7.85 Million
Q4 2022 Feb 10, 2023	SELL	$95.06 - $111.52 $1.16 Million - $1.36 Million	-12,200 Reduced 6.02%	190,400 $20.9 Million
Q3 2022 Nov 10, 2022	SELL	$96.76 - $112.03 $4.71 Million - $5.46 Million	-48,700 Reduced 19.38%	202,600 $19.6 Million
Q2 2022 Aug 15, 2022	SELL	$102.07 - $123.37 $34.6 Million - $41.8 Million	-338,500 Reduced 57.39%	251,300 $27.3 Million
Q1 2022 May 13, 2022	SELL	$114.02 - $139.04 $125 Million - $152 Million	-1,093,400 Reduced 64.96%	589,800 $69.8 Million
Q4 2021 Feb 11, 2022	BUY	$115.53 - $141.46 $48.7 Million - $59.7 Million	421,800 Added 33.44%	1,683,200 $237 Million
Q3 2021 Nov 15, 2021	SELL	$116.66 - $129.06 $23,332 - $25,812	-200 Reduced 0.02%	1,261,400 $149 Million
Q2 2021 Aug 16, 2021	BUY	$105.79 - $124.53 $158,685 - $186,795	1,500 Added 0.12%	1,261,600 $146 Million
Q1 2021 May 17, 2021	BUY	$108.84 - $128.23 $37.4 Million - $44.1 Million	343,600 Added 37.49%	1,260,100 $151 Million
Q4 2020 Feb 16, 2021	BUY	$105.0 - $114.42 $35.2 Million - $38.4 Million	335,700 Added 57.8%	916,500 $100 Million
Q3 2020 Nov 16, 2020	BUY	$91.64 - $111.29 $7.87 Million - $9.56 Million	85,900 Added 17.36%	580,800 $63.2 Million
Q2 2020 Aug 14, 2020	BUY	$76.57 - $98.0 $9.03 Million - $11.6 Million	117,900 Added 31.27%	494,900 $45.2 Million
Q1 2020 May 15, 2020	SELL	$62.82 - $91.86 $10.9 Million - $15.9 Million	-172,800 Reduced 31.43%	377,000 $29.7 Million
Q4 2019 Feb 14, 2020	BUY	$78.51 - $87.4 $4.68 Million - $5.21 Million	59,600 Added 12.16%	549,800 $47.8 Million
Q3 2019 Nov 14, 2019	BUY	$81.84 - $88.74 $5.26 Million - $5.71 Million	64,300 Added 15.1%	490,200 $41 Million
Q2 2019 Aug 14, 2019	BUY	$72.88 - $85.0 $11.4 Million - $13.3 Million	156,200 Added 57.92%	425,900 $35.8 Million
Q1 2019 May 15, 2019	BUY	$66.22 - $80.06 $9.13 Million - $11 Million	137,900 Added 104.63%	269,700 $21.6 Million
Q4 2018 Feb 14, 2019	BUY	$65.56 - $74.27 $3.97 Million - $4.49 Million	60,500 Added 84.85%	131,800 $9.53 Million
Q3 2018 Nov 14, 2018	BUY	$60.81 - $73.36 $1.33 Million - $1.6 Million	21,800 Added 44.04%	71,300 $5.23 Million
Q2 2018 Aug 13, 2018	BUY	$57.57 - $63.54 $2.85 Million - $3.15 Million	49,500 New	49,500 $3.02 Million

Others Institutions Holding ABT

# of Institutions

3,185

Shares Held

1.3B

Call Options Held

8.74M

Put Options Held

8.08M

Vanguard Group Inc Valley Forge, PA

168M
Shares

$19.6 Billion
0.35% of portfolio
Black Rock Inc. New York, NY

131M
Shares

$15.3 Billion
0.31% of portfolio
State Street Corp Boston, MA

76.7M
Shares

$8.96 Billion
0.36% of portfolio
Capital International Investors Los Angeles, CA

65.7M
Shares

$7.68 Billion
1.49% of portfolio
Capital Research Global Investors Los Angeles, CA

53.3M
Shares

$6.23 Billion
1.31% of portfolio

View Full List

About ABBOTT LABORATORIES

Ticker ABT
Exchange NYSE
Sector Healthcare
Industry Medical Devices
Shares Outstandng 1,751,219,968
Market Cap $205B
Description
Abbott Laboratories, together with its subsidiaries, discovers, develops, manufactures, and sells health care products worldwide. It operates in four segments: Established Pharmaceutical Products, Diagnostic Products, Nutritional Products, and Medical Devices. The Established Pharmaceutical Products segment provides generic pharmaceuticals for t...

More about ABT

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Capstone Investment Advisors, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Capstone Investment Advisors, LLC with notifications on news.

Account